Roche inaugurates R&D center in Basel
(CercleFinance.com) - Roche has inaugurated a new pharmaceutical research and early development (pRED) center in Basel, Switzerland.
The center, which required an investment of CHF 1.2 billion, comprises two state-of-the-art laboratory buildings, an office building and a conference center.
It will house around 1,800 researchers and is designed to accelerate scientific discovery and drug innovation.
The project is part of a total investment of CHF 5.8 billion in the Basel/Kaiseraugst site between now and 2030.
Copyright (c) 2024 CercleFinance.com. All rights reserved.